Delivery Order SPE2DB22D3501-SPE2DB26FTG66
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Eucrisa 2% Ointment in 60-gram quantities, with a ceiling value of $1,688.16. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.68 to AmerisourceBergen Drug Corp for the supply of Eucrisa 2% Ointment (60 grams), a topical medication commonly used for dermatological treatments. This non-competitive delivery order, issued on October 31, 2025, represents a firm fixed-price transaction with an ultimate completion date of November 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,545.62 to supply Eucrisa 2% Ointment in 100-gram quantities. This non-competitive, competitively awarded delivery order represents a firm fixed price contract with an ultimate completion date of June 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child order issued under a larger Indefinite Delivery Contract vehicle. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Eucrisa 2% ointment. The contract has a ceiling value of $5,787.65 and a completion date of November 29, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the topical ointment medication Eucrisa (crisaborole) 2% in 60-gram units. The $3,673.74 firm-fixed-price contract has a completion date of February 15, 2023 and does not include any set-aside requirements, indicating open competition. AmerisourceBergen is the prime contractor for this delivery order, which is a part of the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,989.01 to AmerisourceBergen Drug Corp for the supply of EUCRISA 2% Ointment (60 grams). This competitive delivery order, which was not set-aside for any specific business category, carries a firm fixed price structure with an ultimate completion date of August 20, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. EUCRISA is a topical ointment commonly used in...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,777.97 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Eucrisa 2% ointment, a topical medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company, to provide a specialty branded pharmaceutical product - Eucrisa 2% Ointment 60GM. The award, valued at $7,349.06, has an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency awarded a delivery order valued at $1,790.85 to AmerisourceBergen Drug Corp for EUCRISA 2% Ointment (60 gm) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. EUCRISA is a topical calcineurin inhibitor commonly used to treat atopic dermatitis and other inflammatory skin...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Eucrisa 2% ointment. The contract has a ceiling value of $3,364.91 and runs through October 8, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTG66Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,309.44 to AmerisourceBergen Drug Corp for Eucrisa 2% Ointment (60 grams) on October 28, 2025, with an ultimate completion date of October 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, placed under open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, establishing AmerisourceBergen as a comprehensive global pharmaceutical prime vendor for military healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for the Defense Health Agency and military healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a diverse range of pharmaceutical products and medical commodities across multiple therapeutic domains. Eucrisa, a topical immunosuppressant ointment used for treating atopic dermatitis, represents one of the specialized pharmaceutical products the company regularly supplies through its DLA prime vendor contract to support military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 10/28/25 |